2024
DOI: 10.1016/j.jcpo.2024.100473
|View full text |Cite
|
Sign up to set email alerts
|

The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company

Francesco Ferrara,
Maurizio Capuozzo,
Roberto Langella
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 17 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?